PRECISION BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.2 USD | -2.71% |
|
-5.43% | +11.42% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 705.4 | 437.7 | 449.7 | 132 | 44.5 | 84.49 | - | - |
| Enterprise Value (EV) 1 | 524.5 | 347.9 | 308.5 | -35.31 | -49.77 | -3.676 | 20.25 | -19.38 |
| P/E ratio | -6.29 x | -3.99 x | -14.2 x | -0.94 x | -0.69 x | -2.45 x | -2.11 x | -2.43 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 31.7 x | 18 x | 3.89 x | 5.26 x | 0.91 x | 2.68 x | 4.57 x | 4.2 x |
| EV / Revenue | 23.6 x | 14.3 x | 2.67 x | -1.41 x | -1.02 x | -0.12 x | 1.1 x | -0.96 x |
| EV / EBITDA | -6.41 x | -3.44 x | -10.1 x | 0.38 x | 1.35 x | 0.09 x | -0.48 x | 0.34 x |
| EV / FCF | -5.48 x | -3.76 x | -19.4 x | 0.72 x | 0.58 x | 0.05 x | -0.4 x | 0.42 x |
| FCF Yield | -18.2% | -26.6% | -5.16% | 139% | 173% | 2,073% | -250% | 241% |
| Price to Book | 5.14 x | 9.77 x | 4.76 x | - | - | - | - | - |
| Nbr of stocks (in thousands) | 1,693 | 1,749 | 2,026 | 3,699 | 4,064 | 6,926 | - | - |
| Reference price 2 | 416.7 | 250.2 | 222.0 | 35.70 | 10.95 | 12.20 | 12.20 | 12.20 |
| Announcement Date | 3/10/20 | 3/18/21 | 3/15/22 | 3/9/23 | 3/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 22.24 | 24.28 | 115.5 | 25.1 | 48.73 | 31.53 | 18.47 | 20.1 |
| EBITDA 1 | -81.89 | -101.1 | -30.42 | -92.57 | -36.92 | -39.96 | -42.31 | -57.66 |
| EBIT 1 | -87.2 | -109.8 | -39.4 | -100.4 | -43.74 | -56.74 | -76.87 | -83.46 |
| Operating Margin | -392.14% | -452.25% | -34.11% | -399.9% | -89.76% | -179.93% | -416.18% | -415.32% |
| Earnings before Tax (EBT) 1 | -92.88 | -109 | -30.6 | -111.6 | -61.32 | -33.64 | -64.91 | -74.96 |
| Net income 1 | -92.88 | -109 | -30.6 | -111.6 | -61.32 | -33.64 | -64.91 | -74.96 |
| Net margin | -417.65% | -448.86% | -26.49% | -444.8% | -125.84% | -106.68% | -351.38% | -373.01% |
| EPS 2 | -66.30 | -62.70 | -15.60 | -38.10 | -15.96 | -4.976 | -5.778 | -5.020 |
| Free Cash Flow 1 | -95.68 | -92.42 | -15.91 | -49.07 | -86.07 | -76.2 | -50.6 | -46.63 |
| FCF margin | -430.26% | -380.55% | -13.77% | -195.52% | -176.64% | -241.64% | -273.94% | -232.05% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 3/10/20 | 3/18/21 | 3/15/22 | 3/9/23 | 3/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 6.339 | 3.317 | 3.82 | 7.363 | 10.6 | 8.78 | 19.79 | 13.12 | 7.038 | 17.58 | 8.321 | 6.654 | 5.488 | 10 | 13.7 |
| EBITDA 1 | -28.58 | -25.38 | -27.67 | -20.99 | -18.53 | -22.51 | -10.02 | -10.74 | -13.61 | -3.044 | -12.4 | -12.6 | -11.8 | - | - |
| EBIT 1 | -30.75 | -27.35 | -29.6 | -22.93 | -20.49 | -24.46 | -11.99 | -12.36 | -14.89 | -4.187 | -13.68 | -15.24 | -17.01 | - | - |
| Operating Margin | -485.09% | -824.42% | -774.9% | -311.42% | -193.33% | -278.63% | -60.57% | -94.23% | -211.57% | -23.81% | -164.38% | -229.09% | -309.99% | - | - |
| Earnings before Tax (EBT) 1 | -22.29 | -28.17 | -31.04 | -23.95 | -17.22 | -25.06 | -11.89 | -12.11 | -16.29 | 8.588 | -10.72 | -13.16 | -15.18 | - | - |
| Net income 1 | -22.29 | -28.17 | -31.04 | -23.95 | -17.22 | -25.06 | -11.89 | -8.079 | -16.29 | 8.588 | -10.72 | -13.16 | -15.18 | - | - |
| Net margin | -351.63% | -849.2% | -812.43% | -325.22% | -162.46% | -285.42% | -60.09% | -61.58% | -231.44% | 48.84% | -128.79% | -197.72% | -276.58% | - | - |
| EPS 2 | -11.40 | -13.80 | -13.80 | -6.600 | -6.900 | -6.900 | -3.000 | -2.100 | -15.56 | 1.700 | -1.622 | -1.847 | -1.908 | -0.3900 | -0.0700 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/15/22 | 5/9/22 | 8/8/22 | 11/8/22 | 3/9/23 | 5/9/23 | 8/4/23 | 11/7/23 | 3/27/24 | 5/13/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 181 | 89.8 | 141 | 167 | 94.3 | 88.2 | 64.2 | 104 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -95.7 | -92.4 | -15.9 | -49.1 | -86.1 | -76.2 | -50.6 | -46.6 |
| ROE (net income / shareholders' equity) | -104% | -119% | -57.7% | - | - | - | - | - |
| ROA (Net income/ Total Assets) | -49.7% | -56.6% | -21.6% | - | - | - | - | - |
| Assets 1 | 186.9 | 192.7 | 141.4 | - | - | - | - | - |
| Book Value Per Share | 81.10 | 25.60 | 46.60 | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 24.7 | 5.03 | 5.05 | 3.32 | 1.96 | 0.3 | 1.4 | 1.77 |
| Capex / Sales | 110.92% | 20.72% | 4.37% | 13.22% | 4.02% | 0.95% | 7.6% | 8.79% |
| Announcement Date | 3/10/20 | 3/18/21 | 3/15/22 | 3/9/23 | 3/27/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
12.2
USD
Average target price
33
USD
Spread / Average Target
+170.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.42% | 84.49M | |
| +51.85% | 57.87B | |
| +41.42% | 40.25B | |
| -5.25% | 39.94B | |
| -5.16% | 28.54B | |
| +12.79% | 26.4B | |
| -20.18% | 19.33B | |
| +30.88% | 12.4B | |
| +0.61% | 12.23B | |
| +25.06% | 12.2B |
- Stock Market
- Equities
- DTIL Stock
- Financials Precision BioSciences, Inc.
